skip to main content

News Archive

Date: 11/28/2012
About 70% of women who have both breasts removed following a breast cancer diagnosis do so despite a very low risk of facing cancer in the healthy breast, new research from the University of Michigan Rogel Cancer Center finds.
Date: 11/12/2012
Scientists from UT Southwestern Medical Center and the University of Michigan Rogel Cancer Center have developed an innovative model for predicting the progression of skin cancer in patients.
Date: 10/30/2012
Written by Nicole Fawcett
Date: 10/17/2012
The University of Michigan Rogel Cancer Center is part of a national organization that has received $11.5 million to study sarcoma, a rare type of cancer that can occur in bones, muscle and fat.
Date: 09/25/2012
A new multi-million dollar program at the U-M Rogel Cancer Center will examine how patients make treatment decisions, how doctors make treatment recommendations and how to improve the process for better outcomes.
Date: 09/11/2012
Two different genetic mutations cooperate to induce adrenal cancer, according to a new study from researchers at the University of Michigan Rogel Cancer Center and University of Sao Paulo in Brazil.
Date: 08/30/2012
The Center for the Discovery of New Medicines (CDNM) will coordinate and support work in a range of departments and schools to streamline drug discovery and development, support the translation of early research toward patient use -- a gray area where funding is scarce -- and fully leverage the technical capabilities and intellectual resources at U-M in service of discovering the therapies of tomorrow.
Date: 08/28/2012
MidMichigan Health and the University of Michigan Health System have announced plans to affiliate as clinical and business partners, allowing for a collaboration on the development of a major regional cancer center treating the vast array of cancer diagnoses.